C
Charles Catton
Researcher at Princess Margaret Cancer Centre
Publications - 60
Citations - 2346
Charles Catton is an academic researcher from Princess Margaret Cancer Centre. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 23, co-authored 60 publications receiving 1925 citations. Previous affiliations of Charles Catton include University Health Network & University of Toronto.
Papers
More filters
Journal ArticleDOI
Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence
Craig Gerrand,Jay S. Wunder,Rita A. Kandel,Brian O'Sullivan,Charles Catton,Robert S. Bell,Anthony M. Griffin,Aileen M. Davis +7 more
TL;DR: In this paper, the authors considered whether a positive margin occurring after resection of a soft-tissue sarcoma of a limb would affect the incidence of local recurrence, and they found that patients with low-grade liposarcomas were expected to be a low-risk group as were those who had positive margins planned before surgery to preserve critical structures.
Journal ArticleDOI
Cancer-related fatigue and associated disability in post-treatment cancer survivors.
Jennifer M. Jones,Karin Olson,P. Catton,Charles Catton,Neil E. Fleshner,Monika K. Krzyzanowska,David R. McCready,Rebecca Wong,Haiyan Jiang,Doris Howell +9 more
TL;DR: Clinically relevant levels of CRF are present in approximately 1/3 of cancer survivors up to 6 years post-treatment, and this is associated with high levels of disability.
Journal ArticleDOI
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
Chris Parker,Noel W. Clarke,Adrian Cook,Howard Kynaston,Peter Meidahl Petersen,Charles Catton,William Cross,John P Logue,Wendy R. Parulekar,Heather Payne,Rajendra Persad,Holly Pickering,Fred Saad,Juliette Anderson,Amit Bahl,David Bottomley,Klaus Brasso,Rohit Chahal,Peter Cooke,Ben Eddy,Stephanie Gibbs,Chee Goh,Sandeep Gujral,Catherine Heath,Alastair Henderson,Ramasamy Jaganathan,Henrik Jakobsen,Nicholas D. James,S.K. Sundaram,Kathryn Lees,Jason F. Lester,Henriette Lindberg,Julian Money-Kyrle,S L Morris,Joe M. O'Sullivan,Peter Ostler,Lisa Owen,Prashant Patel,Alvan Pope,Alvan Pope,Alvan Pope,Rick Popert,Rakesh Raman,Martin Andreas Røder,Ian Sayers,Matthew S. Simms,James M. Wilson,Anjali Zarkar,Mahesh K. B. Parmar,Matthew R. Sydes +49 more
TL;DR: The initial results do not support routine administration of adjuvant radiotherapy after radical prostatectomy, and an observation policy with salvage radiotherapy for PSA biochemical progression should be the current standard after radical Prostate cancer.
Journal ArticleDOI
Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation.
TL;DR: Implant quality as determined by D(90), V(100, V(200), and urethral dose did not predict AUR, but prostate volume and prior hormone use were found to be independent predictors of AUR.
Journal ArticleDOI
Stage II Testicular Seminoma: Patterns of Recurrence and Outcome of Treatment
Peter Chung,Mary Gospodarowicz,Tony Panzarella,Michael A.S. Jewett,Jeremy Sturgeon,B. Tew-George,Andrew Bayley,Charles Catton,Michael Milosevic,Malcolm J. Moore,Padraig Warde +10 more
TL;DR: In stage IIA/B seminoma, radiotherapy continues to provide excellent results, as the majority of patients will be cured with this treatment alone, and Chemotherapy is the treatment of choice for stage IIC seminoma.